When Things Get Hard
Fact: Some people have a more difficult time with hepatitis C treatment than others.
Tips for traveling with advanced liver disease from blogger, Rick Nash.
Post-transplant, Karen Hoyt talks about the importance of rest for recovery.
The Long Haul
Matt Starr, on overcoming fatigue and buckling down for the end of hep C treatment.
Walking through a typical day of hepatitis C with mom blogger, Kim Bossley.
Hep C Musings
Greg Jeffreys: For some reason, the media is just not interested in hepatitis C.
4 Key Dietary Steps
Connie Welch: We can help our livers function better by changing what we eat and drink.
A Harder Pill
Can we take steps to influence the success of hepatitis C treatment?
Goodbye to the Boys on
A veteran’s compelling story about curing his hepatitis C through the VA.
GlobeImmune’s new hep B treatment lacks strength in Phase II trials.
HCV may actually inhibit HBV among those with both liver diseases.
An Upward Climb
Will we ever have a preventative hepatitis C vaccine?
Treatment as Prevention
Scaling up hep C therapy among gay men in the UK halves new cases.
What are the least-risky HCV treatments for patients coinfected with HIV?
Hep C’s viral network uses some sneaky tricks to dodge the immune system.
Need a Transplant?
Advocates say fewer liver candidates will suffer on waiting lists under this new proposal.
Your Online Hepatitis Community
Check out what everyone's talking about in the Hep Forums.
The Affordable Care Act marks another major victory in the Supreme Court.
Is That Legal?
Veterans Affairs launches a controversial plan to outsource its hepatitis C care.
Treatment Access Victory
Connecticut pushes to make hep C cures easier for low-income patients.
Hep C Lawsuit
Massachusetts inmates sue the state’s prison system for hepatitis C treatment.
Louisiana appeals court denies federal judge’s call to release ‘Angola 3’ inmate with HCV.
On the Edge of Outbreak
Global health experts warn of high hepatitis E risk in post-earthquake Nepal.
Save the Chimps!
Animal activists up in arms after hepatitis researchers abandon 66 test primates in Africa.